MedPath

陕西省万寿制药有限责任公司

Ownership
-
Established
1995-09-04
Employees
-
Market Cap
-
Website
http://www.sxwszy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

22

NMPA:22

Drug Approvals

Vitamin B1 Tablets

Product Name
维生素B1片
Approval Number
国药准字H61021261
Approval Date
Nov 16, 2020
NMPA

Berberine Hydrochloride Tablets

Product Name
盐酸小檗碱片
Approval Number
国药准字H61021263
Approval Date
Nov 16, 2020
NMPA

Vitamin C Tablets

Product Name
维生素C片
Approval Number
国药准字H61021262
Approval Date
Nov 16, 2020
NMPA

Oxytetracycline Tablets

Product Name
土霉素片
Approval Number
国药准字H61021260
Approval Date
Nov 16, 2020
NMPA

Norfloxacin Capsules

Product Name
诺氟沙星胶囊
Approval Number
国药准字H61021257
Approval Date
Nov 16, 2020
NMPA

Compound Sulfamethoxazole Tablets

Product Name
复方磺胺甲噁唑片
Approval Number
国药准字H61021252
Approval Date
Nov 16, 2020
NMPA

Nifedipine Sustained Release Tablets(Ⅰ)

Product Name
硝苯地平缓释片(Ⅰ)
Approval Number
国药准字H20103713
Approval Date
Aug 3, 2020
NMPA

Metronidazole Tablets

Product Name
甲硝唑片
Approval Number
国药准字H61022462
Approval Date
Aug 3, 2020
NMPA

Metoclopramide Tablets

Product Name
甲氧氯普胺片
Approval Number
国药准字H61022924
Approval Date
Aug 3, 2020
NMPA

Paracetamol,Aminophenazone,Gaffeine and Chlorphenamine Maleata Capsules

Product Name
酚氨咖敏胶囊
Approval Number
国药准字H61022835
Approval Date
Aug 3, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.